• News
  • General

Trovagene names new member to its scientific advisory board

San Diego-based Trovagene Inc. (Nasdaq: TROV), a developer of transrenal molecular diagnostics, announced Monday that Dr. Paul Billings has joined the company's scientific advisory board.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments

Trovagene Inc.

Company Website

11055 Flintkote Ave.
San Diego, CA 92121

Trovagene Inc. Executive(s):

Antonius Schuh

  • Chief Executive Officer

Stephen Zaniboni

  • Chief Financial Officer
Subscribe Today!